i-SENS Inc (099190) - Cash Flow Conversion Efficiency
Based on the latest financial reports, i-SENS Inc (099190) has a cash flow conversion efficiency ratio of -0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.56 Billion ≈ $-1.06 Million USD) by net assets (₩356.49 Billion ≈ $241.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 099190 equity to assets ratio to measure how much of total assets are equity-financed.
i-SENS Inc - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how i-SENS Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check i-SENS Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
i-SENS Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of i-SENS Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vizsla Royalties Corp.
V:VROY
|
-0.007x |
|
POLARIS RENEWABLE ENERGY
F:N4T
|
N/A |
|
Ram Essential Services Property Fund
AU:REP
|
0.018x |
|
Alcatel Lucent Teletas Telekomunikasyon AS
IS:ALCTL
|
-0.122x |
|
Sula Vineyards Limited
NSE:SULA
|
0.007x |
|
Braemar Hotel & Resorts Inc
NYSE:BHR
|
0.044x |
|
CERENO SCIENTIFIC AB B
F:4A1
|
-0.151x |
|
Getty Images Holdings Inc.
NYSE:GETY
|
0.067x |
Annual Cash Flow Conversion Efficiency for i-SENS Inc (2012–2025)
The table below shows the annual cash flow conversion efficiency of i-SENS Inc from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see 099190 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩338.32 Billion ≈ $229.28 Million |
₩20.12 Billion ≈ $13.63 Million |
0.059x | -11.16% |
| 2024-12-31 | ₩342.98 Billion ≈ $232.43 Million |
₩22.96 Billion ≈ $15.56 Million |
0.067x | +55.73% |
| 2023-12-31 | ₩303.49 Billion ≈ $205.67 Million |
₩13.05 Billion ≈ $8.84 Million |
0.043x | +84.64% |
| 2022-12-31 | ₩285.81 Billion ≈ $193.69 Million |
₩6.65 Billion ≈ $4.51 Million |
0.023x | -63.73% |
| 2021-12-31 | ₩268.33 Billion ≈ $181.84 Million |
₩17.22 Billion ≈ $11.67 Million |
0.064x | -59.30% |
| 2020-12-31 | ₩219.49 Billion ≈ $148.75 Million |
₩34.61 Billion ≈ $23.46 Million |
0.158x | -17.49% |
| 2019-12-31 | ₩198.56 Billion ≈ $134.56 Million |
₩37.95 Billion ≈ $25.72 Million |
0.191x | +76.94% |
| 2018-12-31 | ₩180.93 Billion ≈ $122.61 Million |
₩19.54 Billion ≈ $13.24 Million |
0.108x | -21.41% |
| 2017-12-31 | ₩162.80 Billion ≈ $110.32 Million |
₩22.38 Billion ≈ $15.16 Million |
0.137x | +75.44% |
| 2016-12-31 | ₩149.67 Billion ≈ $101.43 Million |
₩11.73 Billion ≈ $7.95 Million |
0.078x | -54.15% |
| 2015-12-31 | ₩132.02 Billion ≈ $89.47 Million |
₩22.56 Billion ≈ $15.29 Million |
0.171x | +13.76% |
| 2014-12-31 | ₩118.81 Billion ≈ $80.51 Million |
₩17.85 Billion ≈ $12.09 Million |
0.150x | -3.22% |
| 2013-12-31 | ₩104.32 Billion ≈ $70.70 Million |
₩16.19 Billion ≈ $10.97 Million |
0.155x | +108.16% |
| 2012-12-31 | ₩68.44 Billion ≈ $46.38 Million |
₩5.10 Billion ≈ $3.46 Million |
0.075x | -- |
About i-SENS Inc
i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe.… Read more